Alex Iskold
Angel Investor @ Techstars
New York, United States
Alex Iskold Is a Founder and a Managing Partner at 2048 Ventures. Prior to founding 2048 ventures, Alex spent 5 years at Techstars as the Managing Director of its NYC program. Alex was also the founder and CEO of Info Lab (acquired by IBM), founder and CEO of GetGlue (backed by USV, RRE, and Time Warner), and a Chief Architect of distributedcomputing startup DataSynapse (acquired by TIBCO). Alex currently serves as a Coach and a VC in Residence at the Harvard Business School. Alex previously taught an award-winning undergraduate computer science class at NYU. He holds a B.S. in Math with Honors from Lehigh University and M.S. in Computer Science from NYU.
- Total investments:
- 136
- Last investment:
- Lead investor:
- 32%
Last updated:
For AI agents: llms.txt
Industries Alex Iskold invests in
Stages Alex Iskold invests in
Countries Alex Iskold invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Software 26 (19%)
- Health Care 13 (10%)
- Artificial Intelligence 13 (10%)
- Analytics 12 (9%)
- Information Technology 12 (9%)
Stage
- Pre-Seed 56 (41%)
- Seed 45 (33%)
- Series A 7 (5%)
- Series B 4 (3%)
- Convertible Note 3 (2%)
Country
- United States 80 (59%)
- Canada 7 (5%)
- Israel 1 (1%)
- Nigeria 1 (1%)
- South Korea 1 (1%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Century Health accelerates drug development and commercialization by applying AI to real-world data. It is far too slow today to answer critical questions because the richest clinical data is locked away in silos. Our platform does the heavy lifting to rapidly get you the insight you need, all while supporting the research community and protectingpatient privacy. | $5M / Seed / May 19, 2026 | ||
| IoT-enabled analytics platform providing data-driven optimization of industrial liquid systems for manufacturing | $12M / Series A / Jul 16, 2025 | ||
| Our mission is to redefine the standard of care in pulmonary medicine and deliver the best lung care in America. We’re rebuilding the pulmonary clinic around a technology platform and a set of virtual and physical interventions calibrated to keep lung conditions under control. At a Nimbus Clinic, rich patient data and predictive models allow ourproviders to make more thoughtful medical decisions, and step in at exactly the right moment. | $12M / Seed / May 13, 2025 | ||
| Variant AI is a technology company specializing in applying generative AI to game development. | Pre-Seed / Feb 17, 2025 | ||
| Humane Genomics is a virus development platform that develops artificial viruses to cure diseases. The company was founded in 2019 and is headquartered in New York, United States. | $4M / Seed / Feb 12, 2025 | ||
| IoT-enabled analytics platform providing data-driven optimization of industrial liquid systems for manufacturing | Series A / Jan 16, 2025 | ||
| Impilo is a developer of digital health operating systems aimed at improving the infrastructure underlying remote healthcare. Through its full-stack middleware technology, the company's systems provide an e-commerce and application programming interface for handling purchases, logistics, and configuration, allowing hospitals and healthcareorganizations to manage their digital health remote patient monitoring devices and supplies. | $11.5M / Series A / Nov 14, 2024 | ||
| Nomic is a bioengineering company working to make the human proteome as broadly and easily accessible as the human genome. They are building the nELISA, a next-generation protein profiling platform for measuring proteins at scale and at high throughput. They offer scientists protein profiling solutions and empower them to decide the scope and scaleof their experiments. | $42M / Series B / Sep 17, 2024 | ||
| Growth Signals is an AI-powered system of record and communication for corporate innovation. | Seed / Aug 18, 2024 | ||
| Pioneering the development of AI agents capable of wet lab experimentation. | $2.7M / Pre-Seed / Apr 18, 2024 | ||
| See all 136 investments → | |||
Co-Investors
About Techstars
Techstars is a global platform that provides investment and innovation. Through the Techstars Worldwide Entrepreneur Network, founders and their teams connect with other entrepreneurs, experts, mentors, alumni, investors, community leaders, and corporate partners who will help their companies grow. Techstars operates four divisions: TechstarsMentorship-Driven Accelerator Program supercharges success and Techstars Startup Programs inspire, educate, and connect entrepreneurs. Techstars Venture Capital Fund invests in innovative and disruptive companies. Techstars Corporate Innovation Partnerships help brands create products and services. Techstars accelerator portfolio includes more than 1,000 companies with a market cap of $8.1 billion.
Techstars Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Beata Puncevic
Chief Technology Officer
|
|||
Brad Feld
Co-founder
|
|||
David Cohen
Mentor
|
|||
Jared Polis
Co-Founder
|
|||
|
Jillian Canning
Director
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Alex Iskold invest in?
Alex Iskold invests primarily in Software, Health Care and Artificial Intelligence startups, most often at Pre-Seed and Seed stage. Most of the 136 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Alex Iskold?
Public channels for Alex Iskold include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Alex Iskold last invest?
The most recent investment recorded for Alex Iskold closed in May 2026. Shizune tracks 136 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
